AAAAAA

   
Results: 1-13 |
Results: 13
An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression
Authors: Hemminki, A Belousova, N Zinn, KR Liu, B Wang, MH Chaudhuri, TR Rogers, BE Buchsbaum, DJ Siegal, GP Barnes, MN Gomez-Navarro, J Curiel, DT Alvarez, RD
Citation: A. Hemminki et al., An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression, MOL THER, 4(3), 2001, pp. 223-231
Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging
Authors: Zinn, KR Chaudhuri, TR Buchsbaum, DJ Mountz, JM Rogers, BE
Citation: Kr. Zinn et al., Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging, NUCL MED BI, 28(2), 2001, pp. 135-144
Detection and measurement of in vitro gene transfer by gamma camera imaging
Authors: Zinn, KR Chaudhuri, TR Buchsbaum, DJ Mountz, JM Rogers, BE
Citation: Kr. Zinn et al., Detection and measurement of in vitro gene transfer by gamma camera imaging, GENE THER, 8(4), 2001, pp. 291-299
A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts
Authors: Chaudhuri, TR Rogers, BE Buchsbaum, DJ Mountz, JM Zinn, KR
Citation: Tr. Chaudhuri et al., A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts, GYNECOL ONC, 83(2), 2001, pp. 432-438
Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy
Authors: Chaudhuri, TR Mountz, JM Rogers, BE Partridge, EE Zinn, KR
Citation: Tr. Chaudhuri et al., Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy, GYNECOL ONC, 82(3), 2001, pp. 581-589
A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo
Authors: Reynolds, PN Zinn, KR Gavrilyuk, VD Balyasnikova, IV Rogers, BE Buchsbaum, DJ Wang, MH Miletich, DJ Grizzle, WE Douglas, JT Danilov, SM Curiel, DT
Citation: Pn. Reynolds et al., A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo, MOL THER, 2(6), 2000, pp. 562-578
Gene transfer strategies for improving radiolabeled peptide imaging and therapy
Authors: Rogers, BE Zinn, KR Buchsbaum, DJ
Citation: Be. Rogers et al., Gene transfer strategies for improving radiolabeled peptide imaging and therapy, Q J NUCL M, 44(3), 2000, pp. 208-223
Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with Tc-99m or Re-188
Authors: Zinn, KR Buchsbaum, DJ Chaudhuri, TR Mountz, JM Grizzle, WE Rogers, BE
Citation: Kr. Zinn et al., Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with Tc-99m or Re-188, J NUCL MED, 41(5), 2000, pp. 887-895
Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells
Authors: Dmitriev, I Kashentseva, E Rogers, BE Krasnykh, V Curiel, DT
Citation: I. Dmitriev et al., Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells, J VIROLOGY, 74(15), 2000, pp. 6875-6884
Molecular modification of a recombinant anti-CD3 epsilon-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model
Authors: Vallera, DA Kuroki, DW Panoskaltsis-Mortari, A Buchsbaum, DJ Rogers, BE Blazar, BR
Citation: Da. Vallera et al., Molecular modification of a recombinant anti-CD3 epsilon-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model, BLOOD, 96(3), 2000, pp. 1157-1165
In vivo localization of [In-111]-DTPA-D-Phe(1)-octreotide to human ovariantumor xenografts tnduced to express the somatostatin receptor subtype 2 using an adenoviral vector
Authors: Rogers, BE McLean, SF Kirkman, RL Della Manna, D Bright, SJ Olsen, CC Myracle, AD Mayo, MS Curiel, DT Buchsbaum, DJ
Citation: Be. Rogers et al., In vivo localization of [In-111]-DTPA-D-Phe(1)-octreotide to human ovariantumor xenografts tnduced to express the somatostatin receptor subtype 2 using an adenoviral vector, CLIN CANC R, 5(2), 1999, pp. 383-393
Targeting strategies for cancer radiotherapy
Authors: Buchsbaum, DJ Rogers, BE Khazaeli, MB Mayo, MS Milenic, DE Kashmiri, SVS Anderson, CJ Chappell, LL Brechbiel, MW Curiel, DT
Citation: Dj. Buchsbaum et al., Targeting strategies for cancer radiotherapy, CLIN CANC R, 5(10), 1999, pp. 3048S-3055S
Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N ',N '',N '''-tris(acetic acid)cyclododecane (PA-DOTA)
Authors: Chappell, LL Rogers, BE Khazaeli, MB Mayo, MS Buchsbaum, DJ Brechbiel, MW
Citation: Ll. Chappell et al., Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N ',N '',N '''-tris(acetic acid)cyclododecane (PA-DOTA), BIO MED CH, 7(11), 1999, pp. 2313-2320
Risultati: 1-13 |